NO20063521L - Blandinger, fremgangsmater og anvendelser av en ny peptidfamilie - Google Patents

Blandinger, fremgangsmater og anvendelser av en ny peptidfamilie

Info

Publication number
NO20063521L
NO20063521L NO20063521A NO20063521A NO20063521L NO 20063521 L NO20063521 L NO 20063521L NO 20063521 A NO20063521 A NO 20063521A NO 20063521 A NO20063521 A NO 20063521A NO 20063521 L NO20063521 L NO 20063521L
Authority
NO
Norway
Prior art keywords
methods
mixtures
applications
new peptide
peptide family
Prior art date
Application number
NO20063521A
Other languages
English (en)
Inventor
Yi Wei Jiang
Original Assignee
Texas A & M Univ Sys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M Univ Sys filed Critical Texas A & M Univ Sys
Publication of NO20063521L publication Critical patent/NO20063521L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/345—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Brevibacterium (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Foreliggende oppfinnelse omfatter preparater og metoder for karakterisering og anvendelse av et nytt peptid fra Brevibacillus sp. og peptider beslektet dermed, omfattende et isolert og renset, varmestabilt, amino-terminus-metylert, karboksy-terminus-redusert peptid som har to eller flere D-aminosyrer anvendt som f.eks. et antimikrobielt middel eller også et foradditiv.
NO20063521A 2004-01-30 2006-08-02 Blandinger, fremgangsmater og anvendelser av en ny peptidfamilie NO20063521L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54056904P 2004-01-30 2004-01-30
PCT/US2005/003343 WO2005074626A2 (en) 2004-01-30 2005-01-28 Compositions, methods and uses for a novel family of peptides

Publications (1)

Publication Number Publication Date
NO20063521L true NO20063521L (no) 2006-10-26

Family

ID=34837403

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063521A NO20063521L (no) 2004-01-30 2006-08-02 Blandinger, fremgangsmater og anvendelser av en ny peptidfamilie

Country Status (14)

Country Link
US (2) US7498404B2 (no)
EP (1) EP1765374A4 (no)
JP (1) JP2008508851A (no)
KR (1) KR20070033956A (no)
CN (1) CN101217970A (no)
AU (1) AU2005209901A1 (no)
BR (1) BRPI0507186A (no)
CA (1) CA2554634A1 (no)
EA (1) EA200601408A1 (no)
IL (1) IL177143A0 (no)
MX (1) MXPA06008503A (no)
NO (1) NO20063521L (no)
WO (1) WO2005074626A2 (no)
ZA (1) ZA200606202B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673290B2 (en) 2011-03-01 2014-03-18 MYGALAXY Limited Company Sporulation-deficient B. texasporus cells and methods for efficient and cost-effective inactivation and use thereof
CN102835591B (zh) * 2012-08-14 2017-09-15 北京大北农科技集团股份有限公司 一种易消化的哺乳仔猪教槽料及其制备方法
JP6452607B2 (ja) 2012-09-25 2019-01-16 アキロン セイエレ エセ．エレ． プロバイオティクス組成物及びプレバイオティクス組成物
CN104780931B (zh) * 2012-12-17 2018-05-18 星系有限公司 Bt脂肽作为用于肥胖和相关疾病的治疗剂的用途
WO2015187855A1 (en) 2014-06-03 2015-12-10 The Regents Of The University Of California Non-invasive gene mutation detection in lung cancer patients
RU2603623C2 (ru) * 2014-06-06 2016-11-27 Олег Ильич Эпштейн Ветеринарная композиция и способ улучшения жизнеспособности животных, стимуляции прироста живой массы млекопитающих и птиц, повышения эффективности иммунизации, профилактики и/или лечения инфекционных заболеваний (варианты)
ES2802453T3 (es) * 2016-03-24 2021-01-19 Allflex Europe Sa Uso de una composición acuosa para la disolución de biomoléculas de una muestra de tejido
CN106597681A (zh) * 2017-02-12 2017-04-26 李忠波 一种3d眼镜
CN107347792A (zh) * 2017-07-14 2017-11-17 叙永县元天生态养殖有限责任公司 一种乌骨鸡高山人工饲养方法
CN110577910B (zh) * 2019-09-17 2022-02-01 南京农业大学 一种侧孢短芽孢杆菌、抗菌脂肽及其在农业与食品上的应用
CN111269865B (zh) * 2020-04-01 2020-12-01 北京工商大学 一种侧孢短芽孢杆菌菌株s62-9及其用途
CN111280182B (zh) * 2020-04-01 2020-12-01 北京工商大学 一种活性肽组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504471A (en) * 1982-09-27 1985-03-12 Fujisawa Pharmaceutical Co., Ltd. Animal growth promotant and method of use for animal growth
DE69617641T3 (de) * 1995-01-26 2009-10-22 Novozymes A/S Xylanase beinhaltende futterzusätze für tiere
US5709894A (en) * 1995-06-07 1998-01-20 Biovance Nebraska Feed additive for ruminant animals and a method for feeding a ruminant
DE19909146A1 (de) 1999-03-03 2000-09-28 Mohamed A Marahiel Verfahren zur gezielten biologischen Synthese von Peptiden
CA2337923A1 (en) * 2000-02-25 2001-08-25 Raymond J. Andersen Peptide antibiotics
JP2002058434A (ja) * 2000-08-21 2002-02-26 Nisshin Shiryo Kk 動物用飼料添加物
US6682762B2 (en) * 2001-10-09 2004-01-27 Heart-O-Dixie Animal Nutrition, Llc Poultry and livestock feed additive
PT1448595E (pt) 2001-11-20 2007-02-28 Novozymes As Polipéptideos antimicrobianos de pseudoplectania nigrella

Also Published As

Publication number Publication date
WO2005074626A2 (en) 2005-08-18
ZA200606202B (en) 2008-04-30
JP2008508851A (ja) 2008-03-27
EP1765374A4 (en) 2010-11-03
KR20070033956A (ko) 2007-03-27
AU2005209901A1 (en) 2005-08-18
US20060228398A1 (en) 2006-10-12
US20090175981A1 (en) 2009-07-09
WO2005074626A3 (en) 2007-09-13
US7498404B2 (en) 2009-03-03
IL177143A0 (en) 2008-03-20
EA200601408A1 (ru) 2007-08-31
BRPI0507186A (pt) 2007-06-26
EP1765374A2 (en) 2007-03-28
CN101217970A (zh) 2008-07-09
CA2554634A1 (en) 2005-08-18
MXPA06008503A (es) 2007-01-30

Similar Documents

Publication Publication Date Title
NO20063521L (no) Blandinger, fremgangsmater og anvendelser av en ny peptidfamilie
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
MXPA04003333A (es) Remodelado y glicoconjugacion de peptidos.
RS53872B1 (en) NEW AND POWERFUL CLASS II MHC PEPTIDES DERIVATED FROM SURVIVINE AND UNAURANTS
EP4360651A3 (en) Glp-1 compositions and uses thereof
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
CY1111212T1 (el) Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ
EA200870237A1 (ru) Последовательности пептидов и композиции
NO20071369L (no) Antimikrobiske peptider omfattende et arginin- og/eller lysin-inneholdende motiv
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
ATE553124T1 (de) Oxyntomodulinanaloga und ihre wirkungen auf das fressverhalten
EA200701596A1 (ru) ПРЕПАРАТ АНТИТЕЛА ПРОТИВ Аβ-ПЕПТИДА
CY1110214T1 (el) Μεθοδοι και ενδιαμεσα
HRP20050024A2 (en) Pegylated t20 polypeptide
ATE491349T1 (de) Neue nutrazeutika-zusammensetzungen
AR113422A2 (es) Agentes tensioactivos reconstituidos que tienen propiedades mejoradas
ECSP066495A (es) Composiciones y metodos para inhibir la infección por virus de síndrome de punto blanco (wssv)
CY1109444T1 (el) Φαρμακευτικη συνθεση που περιεχει κυκλικα αναλογα σωματοστατινης
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
DK1536015T3 (da) Promotorer til ekspression i modificeret vacciniavirus Ankara
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
AR066311A1 (es) Moleculas de anticuerpos anti proteina hsp90 fungica y acidos nucleicos que los codifican
EP2305311A3 (en) Glycoconjugation of peptides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application